The RCT Ventures program is the vehicle through which Research Corporation Technologies invests in start-up or early-stage companies with technologies that promise patented biomedical and life science products with a clear competitive advantage.
RCT has assets of more than $200 million to advance technology development through flexible, long-term investment options. Our initial financial commitment to our portfolio companies usually ranges from several hundred thousand dollars to several million dollars, and we reserve additional funds for the subsequent funding of successful companies. We can also invest management resources if needed.
RCT has two primary areas of interest for venture investing: